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Abstract
Background: Methylation at CpG dinucleotides in genomic DNA is a fundamental epigenetic
mechanism of gene expression control in vertebrates. Proteins with a methyl-CpG-binding domain
(MBD) can bind to single methylated CpGs and most of them are involved in transcription control.
So far, five vertebrate MBD proteins have been described as MBD family members: MBD1, MBD2,
MBD3, MBD4 and MECP2.
Results: We performed database searches for new proteins containing an MBD and identified six
amino acid sequences which are different from the previously described ones. Here we present a
comparison of their MBD sequences, additional protein motifs and the expression of the encoding
genes. A calculated unrooted dendrogram indicates the existence of at least four different groups
of MBDs within these proteins. Two of these polypeptides, KIAA1461 and KIAA1887, were only
present as predicted amino acid sequences based on a partial human cDNA. We investigated their
expression by Northern blot analysis and found transcripts of ~8 kb and ~5 kb respectively, in all
eight normal tissues studied.
Conclusions: Eleven polypeptides with a MBD could be identified in mouse and man. The analysis
of protein domains suggests a role in transcriptional regulation for most of them. The knowledge
of additional existing MBD proteins and their expression pattern is important in the context of Rett
syndrome.
Background
Methylation at CpG dinucleotides in genomic DNA is a
fundamental epigenetic mechanism of gene expression
control in vertebrates [1–3]. Strong evidence exists for a
correlation between DNA hypermethylation, hy-
poacetylation of histones, tightly packed chromatin, and
transcriptional repression. Effects of DNA methylation are
mediated through proteins which bind to symmetrically
methylated CpGs. Such proteins contain a specific do-
main, the methyl-CpG-binding domain (MBD) which
consists of ~70 residues in an α/β-sandwich fold built of
three to four β-twisted sheets and a helix with a character-
istic hairpin loop in the opposite layer [4–7]. Recently, a
transcriptional repressor protein, Kaiso, lacking an MBD,
has also been shown to bind to methylated CpG dinucle-
otides. This binding is mediated through zinc finger mo-
tifs [8,9]. Members of the MBD protein family are found
in different animal species. So far, five vertebrate MBD
proteins have been identified as members of the MBD
protein family: MBD1, MBD2, MBD3, MBD4 and MECP2
(for review, see: [6,10]). Except for MBD4, all of them are
associated with histone deacetylases (HDAC), and a tran-
scriptional repression mechanism mediated by the re-
cruitment of HDACs has been shown for MECP2, MBD1
and MBD2 [11–13].
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One of these five MBD proteins, MECP2, is implicated in
a human neurological disorder called Rett syndrome
[14,15]. Symptoms of this syndrome are mental retarda-
tion, loss of speech and purposeful hand use, autism, atax-
ia, and stereotypic hand movements. The similar
phenotype of conditional Mecp2 knockout mice and in vit-
ro studies of functional consequences of MECP2 muta-
tions indicate that the disorder is due to a loss of MECP2
function in the nervous system [16–21]. It remains un-
known, why these patients present with a neurological
phenotype, although MECP2 is ubiquitously expressed. It
has been proposed that MECP2 is complemented by other
MBD proteins in non-neural tissues and this hypothesis
was tested for MBD2 by crossing Mecp2 knockout mice
with Mbd2 knockout mice [19]. However, no evidence for
functional redundancy of these two genes could be found
in this way.
Here we report two new polypeptide sequences with an
MBD as well as four MBD proteins in man and mouse that
had not been mentioned as MBD protein family members
up to date. Analysis of their amino acid sequence revealed
additional domains associated with chromatin and point
to a function in transcription control.
Results and Discussion
Human MBD proteins
We used a bioinformatics approach with the MBD of hu-
man MECP2 as query sequence to search for new mem-
bers of the MBD protein family. Initial standard BLAST
searches of the NCBI, Celera and SwissProt databases re-
sulted only in five MBD proteins (MECP2, MBD1, MBD2,
MBD3 and MBD4) which had previously been described
and studied intensively. However the search of protein
domain family databases (NCBI, Pfam, Smart and
Prosite) revealed similarities to the MBD of MECP2 for
four additional proteins, i.e. BAZ2A/TIP5, BAZ2B, CLLD8
and SETDB1 and for two cDNAs, KIAA1461 and
KIAA1887. These databases use Hidden Markov Models
(HMM) to detect motifs in amino acid sequences. An
MBD has been described in CLLD8, SETDB1 and BAZ2A/
TIP5 so far [22–24].
Nine of the eleven MBD-containing protein sequences
could also be detected by screening the Sequence Similar-
ity DataBase (SSDB) [25] at GenomeNet. The cDNAs for
KIAA1461 and KIAA1887 were not found in the KEGG da-
tabase that underlies the SSDB. These results are summa-
rized in Tab 1. MBD amino acid sequences of the five
previously published and the six newly described human
polypeptides were aligned (Fig. 1). A sequence logo de-
rived from the alignment of all eleven sequences is shown
in Fig. 2. These analyses implicate a small number of high-
ly conserved and apparently essential amino acids within
the domain. At three positions identical amino acids are
present and five positions with conservative substitutions
can be found.
A phylogenetic tree of the MBD amino acid sequences of
all eleven polypeptides is shown in Fig. 3. Four major
MBD subsets are indicated there. The MBDs of the origi-
nally described proteins (MBD1, MBD2, MBD3, MBD4
and MECP2) are found as one group besides a second
(BAZ2A/TIP5, BAZ2B) and third subset (CLLL8 and
SETDB1) which are joined by a very short branch.
KIAA1461 and KIAA1887 appear in a fourth branch.
MBDs of the original five proteins are more similar to
each other than to the novel ones, which explains why
Figure 1
Alignment of the human methyl-CpG-binding proteins according to Swissprot. ClustalX alignment of the human 
MBDs. Columns are colored by conservation and property [50]. Residue conservation above each column indicates: "*" com-
pletely conserved; ":" favored substitutions; "." weakly favored substitutions. A quality graph is depicted below the alignment.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/1
Page 3 of 9
(page number not for citation purposes)
BLAST analyses with the MECP2 MBD query failed to
identify the second, third or fourth class.
Domain analysis
An analysis of the amino acid sequences revealed that the
MBD was the only domain shared by all eleven sequences.
Figure 2
Sequence logo of the eleven human MBD sequences. The height of the letters corresponds to the frequency of the 
amino acid at its position. The size of each stack stands for the information present at this position, measured in bits. Top let-
ters represent the consensus sequence. Grey bars indicate gaps in some of the aligned sequences.
Table 1: Summary of the human MBD polypeptides
Accession No. a) Name Search method / databases b) Domains c) MBD position d)
P51608 MECP2 a, b, c, d, e, f, g, ac, bc, cc 96–149
Q9UIS9 MBD1 a, b, c, d, e, f, g, ac, bc, cc zf-CXXC 7–59
Q9UBB5 MBD2 a, b, c, d, e, f, g, ac, bc, cc 151–204
O95983 MBD3 a, b, c, d, e, f, g, ac, bc, cc 8–60
Q9Z2D7 MBD4 a, b, c, d, e, f, g, ac, bc, cc HhH-GPD 82–135
Q9UIF9 BAZ2A/TIP5 e, f, g AT_hook, DDT, PHD, 
bromodomain
526–577
Q9UIF8 BAZ2B e, f, g DDT, PHD, bromodomain, 549–600
Q96T68 CLLD8 e, f, g SET 162–216
Q15047 SETDB1 e, f, g SET 597–653
Q9P267 KIAA1461 e, f PWWP 21–79
Q96Q00 KIAA1887 e, f 304–456
a) Accession numbers according to the SwissProt database. b) a = BLASTP, b = TBLASTN, c = TBLASTX, d = PSI-BLAST, e = Pfam, f = Ncbi, g = 
SSDB, ac = BLASTP in Celera database, bc = TBLASTN in Celera database, cc = TBLASTX in Celera database. c) domain nomenclature according to 
the Pfam database, all sequences contain an MBD in addition. d) position in amino acid sequenceBMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/1
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The MBD of MECP2, MBD1, MBD2, MBD4 and BAZ2A/
TIP5 mediates binding to DNA, in case of MECP2, MBD1
and MBD2 preferentially to methylated CpG [13,24,26–
28]. MBD4 has a special role acting as a DNA repair en-
zyme that reverses spontaneous CpG to TpG base ex-
changes, thereby maintaining methylated CpG motifs. It
binds preferably to m5CpG/GpT mismatches [29,30].
In case of human MBD3 and SETDB1 the MBD has been
shown to mediate protein-protein interactions [23,31].
Xenopus MBD3 is exceptional in its binding to methylated
CpG which can be explained by the difference of an ami-
no acid residue within the MBD (Lys30) important for
DNA binding [31]. It remains to be determined whether
the MBDs of BAZ2B, CLLD8, KIAA1461 and KIAA1887
mediate DNA binding or protein-protein interactions. Ad-
ditional domains found in seven of the eleven polypep-
tides indicate that they are associated with chromatin and
function in epigenetic mechanisms of gene regulation.
Some of the proteins are already known to be involved in
transcriptional repression, and the domains of the re-
mainder strongly suggest a comparable function.
MECP2 recruits the Sin3A co-repressor complex and
MBD2 the NuRD co-repressor complex, which itself con-
tains MBD3. Both complexes contain HDACs, and MBD1
is also associated with HDAC activity although the identi-
ty of the deacetylase remains unknown [13]. Within the
C-terminal part of MECP2, a histidine and proline-rich re-
gion is present which is conserved in certain neural-specif-
ic transcription factors [32].
BAZ2A/TIP5 is part of the NoRC, nucleolar remodeling
complex, which represses rDNA transcription by recruit-
ing histone methyltransferases, HDACs and DNA methyl-
transferases [33].
BAZ2B has a domain structure similar to BAZ2A/TIP5,
both contain a DDT (DNA binding homeobox and Differ-
ent Transcription factors) and a tandem PHD-bromodo-
main. The PHD domain is a C4HC3 zinc-finger-like motif
and the bromodomain consists of 110 amino acids and is
found in many chromatin-associated proteins that can
interact specifically with acetylated lysine. Tandem PHD-
bromodomains have been found in several transcription-
al co-repressors [34]. The DDT domain is exclusively asso-
ciated with nuclear domains in other proteins and was
found in different transcription and chromatin remode-
ling factors [35]. An AT_hook motif (which allows bind-
ing to the minor groove of AT-rich DNA regions) was
found in BAZ2A/TIP5 but not in BAZ2B.
SETDB1 is a H3-K9 histone methyltransferase [23], its
mouse homologue, ESET, has furthermore been shown to
interact with the mSin3A/B co-repressor complex [36].
The SET domain is a signature motif for lysine-specific his-
tone methyltransferases [37,38]. This domain is also
present in CLLD8 to which no function has yet been
assigned.
The predicted protein sequence of KIAA1461 harbors a
PWWP motif [39] named after the conserved amino acids
Pro-Trp-Trp-Pro. It was first described in the WHSC1 pro-
tein, encoded by a gene within the Wolf-Hirschhorn syn-
drome critical region. The PWWP domain of Dnmt3b, a
DNA methyltransferase, has been recently shown to bind
to DNA. A common feature of PWWP containing proteins
is the presence of additional domains known to be associ-
ated with chromatin [40]. Furthermore KIAA1461 has
been shown to interact with the KIAA1549 protein in a
yeast-two-hybrid experiment (http://www.kazusa.or.jp/
huge/ppi). This interaction partner has not been studied
in detail so far, but contains a serine-rich stretch as well as
a helix-turn-helix motif (PS00622, LuxR family) accord-
ing to Prosite (http://www.expasy.org/prosite). Helix-
turn-helix motifs can be found in many transcription reg-
ulation proteins.
In the predicted protein sequence of KIAA1887, only a
proline-rich extension (http://www.ebi.ac.uk/interpro)
but no protein motif as such could be found.
The co-existence of MBDs and domains involved in chro-
matin modification, present in many of the identified
polypeptides, could also point to a connection between
the latter mechanism and methylated DNA. Interestingly,
a very recent study [41] has shown that Mecp2 is associat-
ed with a H3-K9 methyltransferase activity, indicating a
link between DNA methylation and histone methylation.
MBD proteins in other species
In the mouse, homologues were found for all human
MBD proteins. Sequence identity scores range from 63.8%
to 94.0% (Tab. 2) indicating a conserved function in both
species. Human and mouse MBD1, MBD2, MBD3, MBD4
and MECP2 are curated orthologues [27,42–44].
Homology searches in the ENSEMBL database revealed
the following murine homologues of BAZ2B, CLLD8,
KIAA1461 protein and KIAA1887 protein. The mouse
homologue of BAZ2B, the ENSEMBL protein
ENSMUSP00000028367 (gene ENSMUSG00000026987)
shows a 82.6 % amino acid sequence identity. The pre-
dicted mouse gene ENSMUSG00000021980 coding for
ENSEMBL protein ENSMUSP00000022552 has a 65.2 %
amino acid sequence identity to the human CLLD8. We
furthermore found the predicted gene
ENSMUSG00000036792 coding for the ENSEMBL pro-
tein ENSMUSP00000036847 as mouse homologue of
human KIAA1461 protein with a 94.0 % amino acid se-BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/1
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quence identity. For the KIAA1887 protein, the mouse
gene sequence ENSMUSG00000025409 (ENSEMBL pro-
tein ENSMUSP00000026476) with 91.1 % sequence
identity was present in the database. The latter database
entry however consists of only 101 amino acids. The
existence of translated proteins remains to be determined
for all four mouse genes.
DNA methylation as a mechanism of gene expression reg-
ulation exists also in plants. In our database searches we
detected plant MBD proteins as well. The Pfam database
contains polypeptides from Arabidopsis thaliana and Triti-
cum aestivum. BLAST analyses revealed additional proteins
in Zea Mays, Hordeum vulgare and Lycopersicon esculetum.
Entries for MBD containing proteins from plants over C.
elegans to mouse and human are present in Pfam.
Expression patterns of MBD genes
Expression analyses had been carried out previously for all
genes of the mouse/human MBD family except for
KIAA1461  and  KIAA1887  (only the abundance of
KIAA1887  ESTs in different tissues has been reported
[45]). The results of published Northern blot experiments
are summarized in Tab. 3. Since expression levels of
MBD4 were too low to be detected by Northern blots,
only results of RT-PCR studies in three tissues are shown.
However the presence of MBD4 EST sequences from nu-
merous tissues points to a ubiquitous expression (http://
www.ncbi.nlm.nih.gov/UniGene).
We performed Northern blot analyses for KIAA1461 and
KIAA1887. Strong signals of ~8 kb were detected for
KIAA1461 in skeletal muscle, heart, pancreas, kidney and
placenta. A faint band could be detected in brain, lung
and liver. For KIAA1887 a strong band of ~5 kb was
present in heart, kidney, liver, skeletal muscle, placenta
and pancreas, weaker signals could be seen for brain and
lung tissue (Fig. 4).
Taken together, MBD1, MBD2, MBD3 and MECP2 as well
as  SETDB1, CLLL8, BAZ2A, KIAA1461 and  KIAA1887
show a broad tissue distribution. The expression of BAZ2B
is more restricted according to northern blot results [46].
It is of note that CLLL8, BAZ2A, KIAA1461 and KIAA1887
show a very low expression in brain.
Conclusions
In this study we present additional four proteins and two
cDNAs with a methyl-CpG-binding domain in mouse and
man. Transcripts of SETDB1, BAZ2A, CLLL8, KIAA1461
and  KIAA1887  are found in all adult tissues studied.
Among the six proteins described here as new members of
the MBD protein family, CLLL8, BAZ2B, KIAA1461 and
KIAA1887  show a low expression in brain. MECP2 is
found preferentially in mature neurons of the brain
[47,48], and the cell types that express CLLD8, BAZ2A/
TIP5, SETDB1 as well as the predicted KIAA1461  and
KIAA1887 in brain are not known.
Rett syndrome is caused by mutations in MECP2. Even
though MECP2 is ubiquitously expressed, the phenotype
of the syndrome is restricted to the brain. This could be ex-
plained by a greater need of long lived, non-dividing neu-
ronal cells for a special chromatin state that involves
MECP2 and tightly suppresses transcription of undesired
genes. Another explanation would be that the loss of func-
tion of MECP2 in non-neural tissues is compensated by
another protein with similar properties. MBD2 has been
studied in this respect, but no evidence for a genetic inter-
action of the two genes was found by combining Mbd2-
and Mecp2-null mice [19]. Based on gene expression stud-
ies of Mecp2 knockout mice and biochemical evidence, it
Table 2: Mouse homologues of human MBD proteins
Human protein Mouse protein % identity a)
Human protein Mouse protein % identity a)
MBD1 (645 aa) Mbd1 (713 aa) 66.8 % in 698 aa
MBD2 (478 aa) Mbd2 (454 aa) 93.2 % in 454 aa
MBD3 (331 aa) Mbd3 (362 aa) 85.1 % in 355 aa
MBD4 (647 aa) Mbd4 (631 aa) 63.8 % in 647 aa
BAZ2A (2009 aa) Baz2a (1972 aa) 80.1 % in 2039 aa
BAZ2B (2034 aa) ENSMUSP00000028367 (2065 aa) 82.6 % in 2027 aa
CLLD8 (746 aa) ENSMUSP00000022552 (701 aa) 65.2 % in 715 aa
SETDB1 (1446 aa) ESET (1457 aa) 91.0 % in 1465 aa
KIAA1461 (1544 aa) ENSMUSP00000036847 (1518 aa) 94.0 % in 1521 aa
KIAA1887 (1040 aa) ENSMUSP00000026476 (101 aa) 91.1 % in 101 aa
Comparison of the human MBD proteins and their mouse homologues. Identity scores were calculated with the LALIGN program (http://
www.ch.embnet.org/software/LALIGN_form.html). The numbers of amino acid (aa) residues are indicated. a) The number of aligned amino acids 
can exceed the residue number of the sequences due to gaps inserted by the algorithm.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/1
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has been suggested that the essential function of Mecp2 in
the brain might not be transcriptional [49]. In view of this
aspect and the protein-protein interaction property of the
methyl-CpG-binding domain of human MBD3 and
SETDB1, functional compensation would not necessarily
require a DNA binding property.
Almost all presented polypeptides are known or predicted
to be involved in mechanisms of gene expression regula-
tion. In order to understand the higher-order interplay of
MBD proteins and associated complexes, it will be a major
task to identify interacting proteins as well as regulated
targets of all components. This will help to solve the ques-
tion whether some of the polypeptides can functionally
complement MECP2 in tissues other than the brain.
Methods
BLAST-based and database searches
Non-redundant GenBank, high throughput genomic se-
quences and expressed sequence tag (EST) databases were
searched using BLASTP and TBLASTN of the NCBI web
tools (http://www.ncbi.nlm.nih.gov/blast) applying de-
fault conditions. The human MECP2 chain A (MBD) was
used as a query input. TBLASTX was carried out applying
the web tools at the European Bioinformatics Institute
(http://www.ebi.ac.uk/blast2/).
Using the MBD of human MECP2 as query, the NCBI (ht-
tp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pro-
tein), Pfam (release 7) (http://www.sanger.ac.uk/
Software/Pfam), Prosite (release 17.17) (http://www.ex-
pasy.ch/prosite/) and Smart (version 3.4) (http://
smart.embl-heidelberg.de/) databases were screened for
proteins with this domain. The resulting polypeptides
were sorted according to their species of origin and addi-
tional identified domains within their sequence.
SSDB at GenomeNet (http://ssdb.genome.ad.jp) was
searched with pfm:MBD as query motif. BLASTP and
BLASTN searches were carried out against the Celera data-
base (http://www.celera.com) with standard settings.
Homologues of KIAA1461, CLLL8 and KIAA1887 were
identified in the ENSEMBL database.
Alignment and Phylogeny
Alignments and phylogenetic trees were computed using
the ClustalW program at GenomeNet (http://clustalw.ge-
nome.ad.jp/) with standard settings and the ClustalX pro-
gram (version 1.8) [50] for graphical representation.
The sequence logo was constructed by means of the plogo
script (http://www.cbs.dtu.dk/~gorodkin/appl/plo-
go.html). File formats were converted with the GCG pack-
age (version 10.2) when necessary.
Sequence comparison between mouse and man was car-
ried out using the LALIGN algorithm at EMBNET (http://
www.ch.embnet.org/software/LALIGN_form.html) with
default settings.
Cell lines. RNA and genomic DNA isolation, cDNA 
synthesis
CCRF-CEM and lymphoblastoid cells were grown accord-
ing to manufacturer's instructions (DSMZ, Braunschweig,
Germany and the Coriell Institute for Medical Research,
Camden, Netherlands) and harvested at 95 % confluency.
Genomic DNA was isolated with the QIAGEN Blood
Maxi-KIT (QIAGEN, Hilden, Germany). Total RNA was
Table 3: Expression patterns of the mouse/human MBD genes
Tissue MECP2a) MBD1b) MBD2b) MBD3b) MBD4b) CLLD8c) BAZ2Ad) BAZ2Bd) SETDB1e) KIAA1461f) KIAA1887g)
Brain + + + + + (+) + (+) + (+) (+)
H e a r t ++++ ++++ + +
Kidney + + + + + + - + (+) +
Liver + (+) (+) + + (+) - + (+) +
L u n g ++++ ++ - +( + )( + )
Skeletal 
muscle
++++ ( + )+++ + +
Spleen + + + + + - + +
T e s t i s ++++++++ +
ES cells - (+) + +
Placenta + (+) + + + + +
P a n c r e a s + ++++ + +
The table shows the expression of the eleven MBD genes in major tissues as detected by Northern blot. Empty spaces denote lacking information 
for that tissue. (+) indicates very low or doubtful expression, – no expression. a) [44,51]b) [27] for these genes, comprehensive expression data was 
only available from mouse. c) [22] Expression in additional tissues has been reported. d) [46] Expression in additional tissues has been reported. e) 
[52] SETDB1 was originally called KIAA0067. f) Northern blot results of this study. g) [45] and northern blot results of this studyBMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/1
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isolated using the Trizol reagent (Invitrogen, Karlsruhe,
Germany). A reverse transcriptase reaction was performed
in the presence of 50 ng/µl oligo(dT) and 2 mM dA/C/G/
TTP with 10 U/µl SSII reverse transcriptase (Invitrogen,
Karlsruhe, Germany). The resulting cDNA was purified
with the QIAquick PCR purification kit (QIAGEN, Hilden,
Germany). cDNA (200 ng) was used in subsequent 50- µl
PCR amplifications with 10 pmol gene-specific primers.
Standard PCR conditions and respective annealing tem-
peratures were used.
Northern blotting
A cDNA fragment of KIAA1461 was PCR-amplified with
exon specific primers KIAA1461for (5'-CTAGACCAT-
GGGAAAAATGT-3') / KIAA1461rev (5'-ACTTGGAGACT-
GCTCCTCTA-3') and human genomic DNA as template
using standard conditions. For KIAA1887 a cDNA frag-
ment was PCR-amplified with exon 6 specific primers
KIAA1887for (5'-CAGACCCCCTACTGTATTTC-3') /
KIAA1887rev (5'-CAAAAGGTTAAAGCTTCCAT-3') and
cDNA from a lymphoblastoid cell line as template using
standard conditions. A cDNA fragment of β-actin ampli-
fied with primers β-actinfor (5'-TGAACCCTAAG-
GCCAACCGTG-3') / β-actinrev (5'-
GCTCATAGCTCTTCTCCAGGG-3') was used as a loading
control. These probes were radioactively labeled with 32P-
dCTP in a random prime reaction and hybridized in Ex-
pressHyb solution (CLONTECH, Palo Alto, CA, USA) to a
human multiple tissue northern blot (CLONTECH, Palo
Alto, CA, USA) for 16 h at 65°C. Washing was performed
in 2 × SSC / 0.1% SDS at 65°C for 10 min. Signals were
detected with a PhosphorImager (Amersham Biosciences,
Freiburg, Germany).
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Figure 3
Unrooted dendrogram depicting methyl-CpG-bind-
ing domains of the human protein family. Tree repre-
sentation of the similarity between the human MBD proteins. 
The left branch clusters the original 5 MBD proteins. Branch 
lengths are proportional to the amount of inferred evolution-
ary change.
Figure 4
Northern blot of KIAA1461 and KIAA1887. Human mul-
tiple tissue Northern blot showing the expression of the 
KIAA1461 and KIAA1887 genes. The calculated sizes of the 
transcripts are ~5 kb for KIAA1887 and ~8 kb for KIAA1461. 
A β-actin probe was hybridized as loading control, shown at 
the bottom.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/1
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